Svetlana Aleeva

Biography

Before joining Pharmstandard Ventures (formerly Inbio Ventures), Svetlana served as a head of preclinical research department at IBC Generium, a Russian biotechnology company, since 2012. During this time, under her supervision more than 20 preclinical research programs of potential drugs were developed and carried out, whereas some of them have already successfully entered the stage of clinical evaluation. Previously she worked in the field of somatic stem cell nuclear transfer for obtaining the embryonic stem cells without using of human oocytes, and she has developed a technology of efficient reprogramming of human somatic stem cells to a pluripotent state. Svetlana has more than 8 years of experience in stem cell biology and tissue engineering (creation of human bone, cartilage and skin), in 2007 she received Ph.D. in Immunology and Biotechnology. Her Ph.D. work was devoted to the evaluation of human stem cells from adipose tissue, the creation of three-dimensional structures of human cartilage tissues with the assessment of potential clinical application for regenerative medicine. She underwent specialization at Biology faculty of Moscow State University in the field of Molecular Biology in 2001. She has experience in the Department of Surgery and Intensive Care in Emergency hospital after she graduated from Medical college in 1995.

Research Interest

Before joining Pharmstandard Ventures (formerly Inbio Ventures), Svetlana served as a head of preclinical research department at IBC Generium, a Russian biotechnology company, since 2012. During this time, under her supervision more than 20 preclinical research programs of potential drugs were developed and carried out, whereas some of them have already successfully entered the stage of clinical evaluation. Previously she worked in the field of somatic stem cell nuclear transfer for obtaining the embryonic stem cells without using of human oocytes, and she has developed a technology of efficient reprogramming of human somatic stem cells to a pluripotent state. Svetlana has more than 8 years of experience in stem cell biology and tissue engineering (creation of human bone, cartilage and skin), in 2007 she received Ph.D. in Immunology and Biotechnology. Her Ph.D. work was devoted to the evaluation of human stem cells from adipose tissue, the creation of three-dimensional structures of human cartilage tissues with the assessment of potential clinical application for regenerative medicine. She underwent specialization at Biology faculty of Moscow State University in the field of Molecular Biology in 2001. She has experience in the Department of Surgery and Intensive Care in Emergency hospital after she graduated from Medical college in 1995.